These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 18367152

  • 21. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.
    Economidou D, Fedeli A, Fardon RM, Weiss F, Massi M, Ciccocioppo R.
    Peptides; 2006 Dec; 27(12):3299-306. PubMed ID: 17097763
    [Abstract] [Full Text] [Related]

  • 22. Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness.
    Olszewski PK, Grace MK, Fard SS, Le Grevès M, Klockars A, Massi M, Schiöth HB, Levine AS.
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R655-63. PubMed ID: 20427724
    [Abstract] [Full Text] [Related]

  • 23. Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats.
    Kallupi M, Varodayan FP, Oleata CS, Correia D, Luu G, Roberto M.
    Neuropsychopharmacology; 2014 Apr; 39(5):1081-92. PubMed ID: 24169802
    [Abstract] [Full Text] [Related]

  • 24. Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.
    Johnson EE, McDonald J, Nicol B, Guerrini R, Lambert DG.
    Brain Res; 2004 Apr 02; 1003(1-2):18-25. PubMed ID: 15019559
    [Abstract] [Full Text] [Related]

  • 25. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S, Camarda V, Rizzi A, Marzola G, Salvadori S, Marzola E, Molinari P, McDonald J, Ko MC, Lambert DG, Calo' G, Guerrini R.
    Br J Pharmacol; 2013 Jan 02; 168(1):151-62. PubMed ID: 22827708
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat.
    Economidou D, Cippitelli A, Stopponi S, Braconi S, Clementi S, Ubaldi M, Martin-Fardon R, Weiss F, Massi M, Ciccocioppo R.
    Alcohol Clin Exp Res; 2011 Apr 02; 35(4):747-55. PubMed ID: 21223310
    [Abstract] [Full Text] [Related]

  • 28. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec 02; 378(6):553-61. PubMed ID: 18807245
    [Abstract] [Full Text] [Related]

  • 29. Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats.
    Micioni Di Bonaventura MV, Ubaldi M, Liberati S, Ciccocioppo R, Massi M, Cifani C.
    Psychopharmacology (Berl); 2013 Jul 02; 228(1):53-63. PubMed ID: 23455592
    [Abstract] [Full Text] [Related]

  • 30. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
    Aziz AM, Brothers S, Sartor G, Holm L, Heilig M, Wahlestedt C, Thorsell A.
    Psychopharmacology (Berl); 2016 Oct 02; 233(19-20):3553-63. PubMed ID: 27515665
    [Abstract] [Full Text] [Related]

  • 31. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC, Calo' G.
    Pharmacol Ther; 2013 Oct 02; 140(1):10-25. PubMed ID: 23711793
    [Abstract] [Full Text] [Related]

  • 32. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 02; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 33. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
    Norton CS, Neal CR, Kumar S, Akil H, Watson SJ.
    J Comp Neurol; 2002 Mar 18; 444(4):358-68. PubMed ID: 11891648
    [Abstract] [Full Text] [Related]

  • 34. Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats.
    Li W, Ren Z, Tang Y, Fu Y, Sun S, Ding R, Hou J, Mai Y, Zhan B, Zhu Y, Zuo W, Ye JH, Fu R.
    Neuropsychopharmacology; 2023 May 18; 48(6):908-919. PubMed ID: 36329156
    [Abstract] [Full Text] [Related]

  • 35. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
    Green MK, Devine DP.
    Neuropeptides; 2009 Dec 18; 43(6):507-14. PubMed ID: 19720395
    [Abstract] [Full Text] [Related]

  • 36. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

  • 37. Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat.
    Ciccocioppo R, Stopponi S, Economidou D, Kuriyama M, Kinoshita H, Heilig M, Roberto M, Weiss F, Teshima K.
    Neuropsychopharmacology; 2014 Oct 17; 39(11):2601-10. PubMed ID: 24863033
    [Abstract] [Full Text] [Related]

  • 38. Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.
    Miranda-Morales RS, Nizhnikov ME, Waters DH, Spear NE.
    Behav Brain Res; 2013 May 15; 245():137-44. PubMed ID: 23439216
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.